SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-148358
Filing Date
2021-05-04
Accepted
2021-05-03 18:38:59
Documents
3
Period of Report
2021-04-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d117880d8k.htm 8-K 23910
2 EX-99.1 d117880dex991.htm EX-99.1 14212
3 GRAPHIC g117880g0504002612077.jpg GRAPHIC 3107
  Complete submission text file 0001193125-21-148358.txt   43768
Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39401 | Film No.: 21885169
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences